For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Varonis Systems, Inc. (VRNS) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Low · Gem Score -22 (−100…+100 Quality+Value blend) · Quality 10 · Value -54 · Sentiment -45 (timing only, not weighted)
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Varonis Systems, Inc.
VRNS NASDAQVaronis Systems, Inc. is a cybersecurity software company specializing in data and AI security for enterprise environments worldwide. Headquartered in Miami, Florida and founded in 2005, Varonis focuses on protecting sensitive business information such as files, emails, financial records, and intellectual property across cloud, SaaS, IaaS, and hybrid infrastructures. Its core offering is the Varonis Data Security Platform, a cloud-native solution that continuously discovers and classifies critical data, maps permissions, monitors activity, and automates remediation to reduce exposure and detect advanced threats. Complementary products and services include Varonis Atlas for governing AI tools and agents, managed data detection and response, and professional services to support governance, compliance, and threat analytics. Varonis serves primarily mid-market and large enterprises in regulated and data-intensive sectors including financial services, healthcare, government, technology, energy, and retail, operating on a subscription-led SaaS model. In the cybersecurity market, Varonis occupies the data security layer, providing organizations with specialized capabilities for data security posture management, access governance, insider risk management, and AI-aware protection rather than broader network or endpoint defense.
Price Overview
High Free Float & Insider Alignment
The data point on the page
VRNS shows 94.6% free float with ~5.4% closely held. Underneath that, public filings put total insider ownership at roughly 2.5%, with founder/CEO Yaki Faitelson holding around 1.7M shares (~1.4% of the company) — about $48M at the current price.
By itself a high free float reads as "healthy liquidity." But the same number means low insider stake, and that has two opposite implications depending on which way the wind blows.
What high free float usually means
In a normal mature-software company (10+ years public, heavy SBC history), insider ownership in the 1–5% range is typical. Salesforce, ServiceNow, and Adobe all sit in that band. The founders sold down or got diluted; institutional asset managers (Vanguard, BlackRock, T. Rowe Price) hold most of the shares.
High free float makes the stock easy to trade — large positions don't move the price, bid-ask spreads stay tight, options markets are deep. That's the "Very liquid" framing on the card.
Why it matters more here
For a company in transition like VRNS — phasing out on-prem, completing the SaaS shift, fighting Microsoft Purview on price — who owns the company shapes how management behaves. Two things follow from a 2.5% insider footprint:
Weak day-to-day alignment. Management is compensated mostly in fresh stock grants, not anchored by a large ownership stake. They get shares each year, vest them, sell some, get more. The incentive structure rewards "keep getting paid" more than "maximize per-share intrinsic value." When the CEO has $48M in stock, a 50% drawdown costs him $24M — meaningful, but not the existential threat it would be for a founder with 20% of the company. Charlie Munger's old line — show me the incentive and I'll show you the outcome — applies hard here.
Easier path to acquisition. The flip side: no blocking holder means no founder veto on a takeover. A Microsoft, Palo Alto Networks, or CrowdStrike bid at $35 (~30% premium) goes to a vote of independent directors who own modest stakes themselves. There's no Mark Zuckerberg figure to refuse a lowball offer because he wants to build for another decade. The synthesis output explicitly notes this dynamic: "The most likely outcome is actually a take-private or strategic acquisition at $32-38/share within 18-24 months… investors are pricing in acquisition optionality."
These two implications sit in tension. The same low-insider-ownership structure that creates an agency problem in calm periods creates a price floor through M&A optionality in distressed ones.
What would actually change the picture
The single most informative signal would be Faitelson buying VRNS in the open market — not RSU vesting, not option exercise, but cash-purchased shares at current prices. A CEO with $48M already at stake who decides to add more from his own pocket is signaling that he sees something the market doesn't. None of that has been visible in recent filings.
The Opus narrative flagged the related quirk: the "net insider buying" tag in the pipeline output was mis-classified — it was reading ten identical 7,224-share board grant awards on the same day as "buying," when in fact it's just the annual compensation cycle. There's no genuine insider conviction signal in the recent data, in either direction.
Practical framing
Two things follow from this if you're sizing a VRNS position:
1. Don't over-size on the bull thesis alone. The 2.5% insider footprint means the company is vulnerable to slow value destruction — bloated comp packages, ill-advised acquisitions, prioritizing growth over discipline — that a founder-controlled company would resist harder. 1-3% portfolio sizing is more appropriate than the 3-5% you might consider for a comparable founder-led name.
2. The takeout floor is real, not theoretical. The same structure that creates the agency risk makes M&A genuinely plausible. Strategic acquirers see VRNS as digestible at a $3-4B EV, and there's no one with 20% who can refuse. That doesn't make the stock a buy on its own, but it does cushion the downside meaningfully more than it would for a founder-controlled competitor.
The honest framing isn't "this is a problem" or "this is fine." It's that shareholder-friendly behavior here depends on institutional pressure and board discipline rather than founder economics — and those are weaker, less reliable governors than skin in the game. Worth keeping in mind, not a thesis-killer.
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -1.13
Total Equity: $598.66M
Shares: 114,413,076
Total Debt: $0.00
Cash: $202.48M
EBITDA: -$134.21M
Total Debt: $0.00
Cash: $202.48M
Revenue: $623.53M
Shares: 114,413,076
Revenue: $623.53M
Revenue: $623.53M
Revenue: $623.53M
Total Equity: $598.66M
Tax Rate: -11.2%
Equity: $598.66M
Total Debt: $0.00
Cash: $202.48M
Current Liabilities: $658.96M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $598.66M
Shares: 114,413,076
Shares: 114,413,076
CapEx: -$12.63M
Shares: 114,413,076
Stock Price: $39.94
Net Income: -$129.32M
Industry Benchmarks
Income Statement (Annual)
Last updated: Jul 30, 2026 6:27pm (24d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $390.1M | $473.6M | $499.2M | $551.0M | $623.5M |
| Cost of Revenue | $59.4M | $69.8M | $71.8M | $93.8M | $132.0M |
| Gross Profit | $330.7M | $403.8M | $427.4M | $457.1M | $491.6M |
| Operating Expenses | $429.4M | $525.0M | $544.6M | $574.8M | $638.1M |
| Operating Income | -$98.7M | -$121.2M | -$117.2M | -$117.7M | -$146.5M |
| Net Income | -$116.9M | -$124.5M | -$100.9M | -$95.8M | -$129.3M |
| EBITDA | -$87.8M | -$109.1M | -$105.5M | -$106.5M | -$134.2M |
| EPS | $-1.11 | $-1.14 | $-0.92 | $-0.86 | $-1.13 |
| EPS (Diluted) | $-1.11 | $-1.14 | $-0.92 | $-0.86 | $-1.13 |
Balance Sheet (Annual)
Last updated: Jul 30, 2026 6:18pm (24d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $805.8M | $367.8M | $230.7M | $185.6M | $202.5M |
| Total Current Assets | $959.2M | $905.7M | $767.2M | $878.1M | $1.3B |
| Total Assets | $1.1B | $1.0B | $1.1B | $1.7B | $1.8B |
| Current Liabilities | $211.8M | $228.7M | $306.8M | $709.9M | $659.0M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $511.9M | $541.6M | $614.3M | $1.2B | $1.2B |
| Total Equity | $596.6M | $502.1M | $489.6M | $455.7M | $598.7M |
| Retained Earnings | -$427.6M | -$543.5M | -$644.4M | -$740.2M | -$869.5M |
Cash Flow (Annual)
Last updated: Jul 30, 2026 6:27pm (24d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7.2M | $11.9M | $59.4M | $115.2M | $147.4M |
| Capital Expenditure | -$10.5M | -$11.4M | -$5.1M | -$6.7M | -$12.6M |
| Free Cash Flow | -$3.3M | $475,000 | $54.3M | $108.5M | $134.8M |
| Acquisitions (net) | $0 | $0 | — | — | — |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | -$56.4M | -$43.5M | $0 | -$115.0M |
| Net Change in Cash | $571.7M | -$438.0M | -$137.1M | -$45.2M | $16.9M |
Growth Trends (YoY %)
Last updated: Jul 30, 2026 6:27pm (24d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +21.4% | +5.4% | +10.4% | +13.2% |
| Gross Profit Growth | +22.1% | +5.8% | +6.9% | +7.5% |
| Operating Income Growth | -22.8% | +3.3% | -0.4% | -24.5% |
| Net Income Growth | -6.6% | +19.0% | +5.1% | -35.0% |
| EBITDA Growth | -24.2% | +3.2% | -1.0% | -26.0% |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-19 11:15Even the bull case prices 40% below today — the ratio here measures the model-vs-market gap, not payoff odds. Another quarter like the worst recent one costs 100%. Caveat: the company is pre-profit — scenario margins are a glide-path assumption, not a track record.
| Case | Growth | Margin | Fair value | vs price ($39.94) |
|---|---|---|---|---|
| Bull — recovery | +33% | 17.3% | $24.04 | -40% |
| Base — stabilizes | +22% | 15.0% | $14.61 | -63% |
| Bear — keeps slipping | +11% | 12.8% | $8.29 | -79% |
| Stress — last quarter repeats | +27% | -20.6% | $0.00 | -100% |
Narrative Economics
market-narrative step).
Claude Reading
The raw trajectory here is more interesting than the "priced for perfection" label suggests. Revenue grew from $130.3M in Q2 2024 to $173.1M in Q1 2026 — that's ~33% over seven quarters, and the recent YoY comps (Q1'26 $173.1M vs Q1'25 $136.4M = +26.9%; Q4'25 $173.4M vs Q4'24 $158.5M = +9.4%) suggest the SaaS transition is inflecting rather than decelerating. The 5-year revenue CAGR of 11.8% understates the current run-rate because it averages through the subscription conversion trough. Gross margin at 78.8% is genuine software economics. FCF of $134.8M on $623.5M revenue is a 21.6% FCF margin — that is not a "pre-profit" company in the venture sense; that is a company deliberately running GAAP losses via stock-based comp while generating real cash. The GAAP net loss widening to -$129M in 2025 while FCF grew is almost entirely an SBC story, and the insider "F-InKind" activity (tax withholding on vesting) plus the eight identical 7,224-share awards on the same day confirm the dilution engine is running hot.
Where I part ways with the synthesis: calling this "Priced for Perfection" at 7.3x sales and 7.2x EV/revenue is lazy for a 78% gross margin software company growing high-teens/mid-20s with 22% FCF margins. Comparable data-security and identity peers (CRWD, ZS, S) trade at 12-20x sales with similar or worse FCF conversion. VRNS at 4.7B market cap / $135M FCF = 35x trailing FCF, and if FCF compounds even 25% (well below the 57.5% CAGR), you're at ~$210M FCF in two years and 22x forward — cheap for the category. The Market Forces "neutral" and Narrative "unanchored/turnaround-bet" reads both underweight the fact that the SaaS transition math is now visible in the numbers: this isn't a story stock, it's a mechanical re-rating candidate as ARR compounds and GAAP losses narrow.
The contrarian case is real and I want to steelman it. First, SBC-funded FCF is not shareholder FCF — if you subtract ~$150M+ of annual SBC (implied by the gap between GAAP loss and cash generation), "true" owner earnings are near zero or negative. Second, Microsoft Purview is bundled free-ish with E5 licenses and is genuinely improving; Varonis's moat in unstructured data classification is narrowing. Third, the Q4'25→Q1'26 revenue is flat ($173.4M → $173.1M) — the sequential deceleration could indicate the SaaS transition tailwind is fading and underlying growth is closer to 10-12% than 20%+. Fourth, "9,000 customers" after 20 years in market is not a land-grab story; it's a mature vendor. Fifth, the insider data shows zero open-market buying — only awards and tax withholding. The "Significant Insider Buying" secondary signal appears to be misreading vesting activity as conviction, which is a data-quality problem worth flagging.
Netting this out: the models are internally contradictory (Priced for Perfection + Significant Insider Buying + Weak Cash Flow Quality + High Revenue Confidence can't all be load-bearing simultaneously), and the "perfection" framing over-anchors on the negative GAAP optics. On a cash basis, VRNS at $39.94 trades at 35x trailing FCF for a business growing ARR mid-20s with 78% gross margins in a secularly tailwinded category — that's a reasonable, not stretched, multiple. Fair value with 20% FCF growth and a 30x exit multiple in two years is roughly $50-55. The real risks are SBC dilution (share count creep of 3-5%/yr eats into per-share returns) and Microsoft bundling pressure, neither of which shows up yet in the top-line. I dissent partially from the "Priced for Perfection" synthesis — the stock is closer to fairly valued with modest upside, not priced for perfection, and certainly not a short. But I don't share the pre-flight model's implicit bullishness either; the SBC-adjusted picture makes the "FCF inflection" less clean than it looks. I'd be a buyer under $35, a holder here, and a trimmer above $50 absent a clear ARR acceleration print.
GPT Reading
What jumps out first is that Varonis is being valued like a healthy growth compounder while the income statement still looks like a business stuck in transition. Revenue has clearly improved: $551.0M in 2024 became $623.5M in 2025, up 13.2%, and the quarterly cadence accelerated from $130.3M in Q2’24 to $173.4M in Q4’25 and $173.1M in Q1’26. On a trailing four-quarter basis through Q1’26, revenue is about $660M, so the stock at $4.69B market cap trades around 7.1x trailing sales, consistent with the EV/revenue figure. That multiple would be defendable for a software name if margins were inflecting hard. They are not. Gross margin is excellent at 78.8%, but operating losses worsened from -$117.7M in 2024 to -$146.5M in 2025, and net loss widened from -$95.8M to -$129.3M. Even as revenue grew, the company gave back operating leverage.
The quarterly pattern is even more revealing. Q1’26 revenue of $173.1M was up 26.9% year over year from $136.4M, which is the kind of number bulls will lead with. But net loss in that same quarter was -$36.9M, essentially unchanged in dollars from -$35.8M a year earlier, and worse in margin than Q4’24 or Q1’25’s path would have implied. Across the last five reported quarters, net margins stayed between -16.0% and -26.2%. That is not a business proving scale economics yet; it is a business proving that growth still requires heavy spending. The balance sheet is clean with no debt and $202.5M of cash, so solvency is not the issue. The issue is paying 7x sales for a company with a 20% net margin deficit after two decades in market.
The cash flow argument is real but I don’t think it closes the gap. Operating cash flow of $147.4M and free cash flow of $134.8M in 2025 are strong relative to the income statement and imply a 2.9% FCF yield on market cap. For a software company in conversion mode, that is helpful, but not cheap. More importantly, when GAAP losses are this persistent, I assume a meaningful share of the FCF benefit comes from billing mix, deferred revenue dynamics, and non-cash add-backs rather than a fully matured earnings engine. That does not make the cash fake; it just means I won’t capitalize it at a premium multiple as if it were clean, repeatable owner earnings. At nearly 8x book and with negative ROE, this is still a faith-in-the-transition stock.
The best case against my skepticism is straightforward: the market may be correctly looking through GAAP losses because the subscription shift is working. Revenue has stepped up from $390.1M in 2021 to $623.5M in 2025, a 12% CAGR, while free cash flow has turned decisively positive. Q1’26’s 26.9% revenue growth is materially stronger than the full-year CAGR and suggests momentum may be improving, not fading. A debt-free balance sheet gives management time, and in software, gross margin near 79% means there is a large latent earnings pool if sales and marketing intensity normalizes. If the company can sustain even low-20s growth while keeping FCF above $130M and showing just modest opex discipline, then 7x sales is not crazy for a cybersecurity asset tied to data governance and AI-era security demand.
What would change my mind is evidence that the revenue acceleration is durable and not merely optically strong against a soft compare, paired with real operating leverage. Specifically, I would want to see at least two more quarters above 20% year-over-year revenue growth and net loss dollars moving down meaningfully, not sideways — for example, quarterly net losses improving from the current roughly -$30M to -$40M range into the teens while holding gross margin near 79%-80%. Full-year revenue moving toward a $700M+ run rate with operating margin improving by 500 bps or more would support the current valuation and probably more. Absent that, I think the stock is priced ahead of the proof; at roughly $40, investors are paying for a margin structure that has not yet arrived.
Grok Reading
The numbers on Varonis describe a company that has already made the hard turn from cash-burning growth story to cash-generative mid-teens compounder, yet the market still prices it like the former. Annual revenue climbed from $390M in 2021 to $623.5M in 2025—an 11.8% CAGR that is respectable but nowhere near the “high-growth” label the pre-flight model attaches. The latest four quarters show $136M → $152M → $162M → $173M → $173M, so the sequential stall at $173M in the March 2026 quarter is the first real crack in the trajectory. Gross margin sits at a clean 78.8% and free cash flow has inflected hard to $134.8M (22% FCF margin) on only $12.6M of capex, with zero debt and $202M cash. That FCF conversion is the single most important fact in the briefing: the business is no longer consuming capital. GAAP losses remain stubborn—operating margin –23.5%, net loss $129M in 2025—so the $4.69B market cap and 7.3× sales multiple rest almost entirely on the cash-flow story and the AI-data-security narrative, not on earnings power that exists today.
What stands out against the prior models is how casually they wave away the growth rate. Calling 12% revenue growth and a flat sequential quarter “priced for perfection” is directionally right, but the implied 18–25% sustained growth needed to justify 7× sales is already optimistic relative to the five-year record. The 57.5% FCF CAGR is real and impressive, yet it is largely the arithmetic of a company that stopped spending as aggressively rather than one that is accelerating top-line capture. Insider activity labeled “significant buying” is simply award grants and tax-withholding dispositions; there are no open-market purchases in the tape. Sector-relative lag and macro headwinds are acknowledged by the secondary signals and should not be dismissed. At $39.94 the stock offers a roughly 2.9% FCF yield on trailing numbers—adequate for a software franchise with fortress gross margins, but thin compensation if growth settles into the low teens and the Microsoft bundling risk materializes.
The strongest contrary case is straightforward: positive and expanding free cash flow in cybersecurity is scarce, 79% gross margins give enormous operating leverage once growth reaccelerates, and the AI-governance / unstructured-data tailwind is genuine rather than invented. A bull can argue that the March quarter was seasonality, that the $173M run-rate already embeds 27% year-on-year growth versus the year-earlier $136M quarter, and that 7× sales for a debt-free, FCF-positive data-security platform is not expensive if the company simply holds mid-teens growth while expanding FCF margins another 500–800 bp. That path would make today’s price look like a reasonable entry rather than a premium. I weigh it less heavily because the five-year revenue CAGR has compressed steadily, the most recent sequential print was zero, and the company has spent two decades promising the operating-leverage moment without delivering GAAP profitability. Narrative durability is moderate, not cult-level; patience can expire.
I would flip to a clear undervalued stance if the next two quarters show sequential revenue reacceleration above $185M and trailing FCF run-rate breaking $160M while management guides to high-teens growth. Conversely, another flat or down sequential quarter combined with FCF margin compression would confirm the mid-teens trap and push fair value into the low $30s.
Big-3 Panel — where each AI stands
Claude — Second Response · fairly valued changed direction
VERDICT: Fairly valued at $39.94 — revised band $38-44; sequential stall and SBC dilution close the gap I previously saw, downside to low-$30s if Q2 prints flat again
The two colleague reads did move me on one specific thing: I was too casual about the Q4'25 → Q1'26 sequential flatline ($173.4M → $173.1M). I dismissed it in my first pass as noise, but Grok correctly frames it as the first real crack in the trajectory, and GPT's point that the YoY comp is flattered by a soft $136.4M Q1'25 base is fair. If the true underlying growth is low-to-mid teens rather than the 26.9% headline, then my "35x trailing FCF, cheap for the category" framing loses force — because the category comp (CRWD, ZS, S) is 25%+ growers, and a 12-15% grower doesn't get 7x sales, it gets 4-5x. That's a real gap I underweighted.
Where I still hold: GPT's $28-32 fair value requires capitalizing the FCF at a meaningfully lower multiple than software peers, and I don't think a 22% FCF-margin, 79% gross-margin, debt-free business with $200M cash trades below 20x FCF absent a broken thesis — that math implies ~$27, which is a distress multiple for economics that aren't distressed. Grok's low-$30s downside case is more defensible and closer to where I'd actually put the floor. The SBC dilution issue that I raised myself also cuts against my own $50-55 upside; if I take it seriously (and I should), fair value compresses toward $42-46, not $50-52. Neither colleague made me more bullish; both made the sequential-stall risk more concrete than I'd priced.
Net: I'm revising down but not flipping. The "mechanical re-rating candidate" language in my first read was too confident given one flat sequential quarter and no open-market insider buying. Fair value band moves from $48-52 to roughly $38-44 — meaning the stock is closer to fairly valued than modestly undervalued, with asymmetric downside if the next print is flat again. I won't drift to "overvalued" because the cash economics are real and the balance sheet buys time, but I concede the margin of safety I claimed isn't there.
GPT — Second Response · overvalued revised
VERDICT: Still modestly overvalued at $39.94; fair value nudges up to roughly $32-$36, with upside to $45+ only if >20% growth and real per-share operating leverage become visible.
Claude’s pushback moved me on one point: I underweighted just how strong the cash economics already are for a company still wearing ugly GAAP optics. A 21%-22% FCF margin on 79% gross margin software is not trivial, and 35x trailing FCF is not an absurd multiple if recent ~27% YoY growth is the right lens rather than the 5-year CAGR muddied by the subscription conversion. That said, his bull case leans heavily on treating current FCF as near-owner earnings while acknowledging SBC likely absorbs most of the gap between GAAP losses and cash generation. That is exactly the bridge I’m unwilling to cross at a premium multiple. If “true” economic earnings are near breakeven after dilution, then the stock is not obviously cheap simply because reported FCF is healthy.
Grok largely reinforced my original caution, especially on the sequential stall and maturity point. The Q4’25 to Q1’26 flatline at ~$173M does not disprove the turnaround, but it does weaken the argument that the business has clearly broken into a sustained 20%+ growth regime deserving a category-leader multiple. I also agree the insider “buying” signal should be discarded; vesting/tax-withholding is not demand. Where I revise slightly is in degree, not direction: “overvalued” still fits, but less emphatically than my first pass because Claude is right that 7.2x EV/revenue is not “priced for perfection” in absolute software terms given the cash generation and balance sheet. The issue is not that the multiple is crazy; it is that the evidence for durable acceleration and clean per-share cash compounding is still incomplete. I’d move my fair range up modestly to reflect the stronger-than-I-credited FCF profile, but I still need either sustained >20% growth or visible SBC-adjusted margin improvement before paying $40.
Grok — Second Response · fairly valued changed direction
VERDICT: Fairly valued at $39.94 — 7× sales and ~30× NTM FCF fair for 22% FCF margins + 27% YoY, but no margin of safety until opex leverage shows
Claude’s peer-multiple and run-rate points are the data I underweighted. At 7.3× trailing sales versus CRWD/ZS/S at 12-20×, with 78.8% gross margins and a visible 22% FCF margin already in hand, the “priced for perfection” label does overstate the stretch; the 26.9% Q1 YoY print and the fact that the 11.8% five-year CAGR averages through the SaaS trough make the current trajectory look more like mid-20s ARR compounding than a low-teens trap. That relative cheapness and the mechanical re-rating case if FCF simply holds $135M+ while share-count creep stays contained move me off a clear overvalued stance.
GPT’s operating-leverage critique and the SBC adjustment still bite, however. Losses widened in dollars even as revenue stepped up, sequential revenue was flat, and true owner earnings after ~$150M SBC are far thinner than the headline 2.9% FCF yield. Microsoft bundling and the absence of open-market insider buying remain unaddressed risks. Those facts keep me from chasing Claude’s $48-52 fair-value target; the stock is closer to a hold than a buy until two clean quarters of sequential reacceleration and narrowing GAAP losses appear.
Net: current price embeds a reasonable but not generous multiple for the cash economics on offer. I would add only on a pullback toward $35 or on proof of leverage.
Advanced Analysis Forensic deep-dive · separate lenses
Varonis is a well-capitalized, growing infrastructure software business transitioning to SaaS. Revenue has compounded from $390M (2021) to $623M (2025), roughly 12.5% CAGR, and FCF has swung from essentially zero in 2022 to $134.8M in 2025 - a genuine inflection. The balance sheet is a fortress: $883.7M liquid cash, zero net debt, and self-funding operations, so survival risk is nil. Mechanical earnings-quality checks are clean (Beneish -3.1, accruals -13.4% of assets, no manipulation flags), though Altman Z of 2.19 sits in the grey zone which is normal for a still-GAAP-unprofitable software name. The concerns are structural, not fraudulent. GAAP operating margin has been stuck in the -21% to -26% band for five straight years with no visible improvement despite scale - 2025 opM of -23.5% is worse than 2024's -21.4%, and gross margin actually compressed from 85.6% (2023) to 78.8% (2025), likely the SaaS transition drag. SBC runs 20.9% of revenue, an enormous real cost that adjusted metrics hide, and buybacks only offset 33% of it, so diluted share count keeps creeping (105.3M to 114.4M, ~2.1%/yr). Insider tape shows the typical pattern of tax-withholding on vesting and awards - the flagged 'insider buying' is not visible as open-market P transactions in the tape provided, so I would not weight that heavily.
Verify before trusting this (5)
- Confirm whether the flagged insider P-purchases exist in Form 4 filings outside the shown 15-line window (the tape shown is all F/A codes)
- Review SaaS ARR growth and net retention rate in the 10-K to gauge whether the gross margin compression is transitory transition drag or a permanent step-down
- Check management's stated path to GAAP profitability and whether operating leverage is projected as ARR ramps
- Verify customer concentration and enterprise renewal metrics from the 10-K
- Examine detail of SBC grants: are they front-loaded transition-related or a steady-state 20%+ of revenue
The e2e synthesis flags 'priced for perfection' and the bear case pegs implied growth at roughly 39% to justify today's cap - that is the deserved-value tell. Varonis is a solid business (fortress balance sheet, real FCF inflection, credible data-security positioning in an AI world), but 'solid' is not 'exceptional,' and at ~$4.7B on a company still posting -20%+ GAAP operating margins with SBC at ~21% of revenue, the market is already paying for the bull thesis to land cleanly. Earnings quality is fine, so no haircut there - but there is also no hidden cash-adjusted bargain to surface. Deserved value for a mid-teens growing SaaS name completing an ARR transition, with genuine FCF but persistent GAAP losses and heavy dilution, is roughly a market-multiple SaaS name - not a premium one. Against that, $39.94 looks full rather than egregious. I don't see a margin of safety, I see a fair-to-full price where you underwrite execution and get paid only if Atlas/AI-governance actually accelerates ARR. That's a coin flip, not a mispricing in your favor.
Verify before trusting this (5)
- Latest ARR growth rate and net revenue retention post-SaaS transition
- GAAP operating margin trajectory and whether SBC as % of revenue is finally trending down
- FCF guidance for next fiscal year and share-count dilution rate
- Atlas/AI-governance attach rates or contribution disclosed on the call
- Any change in long-term operating margin target from management
VRNS is caught in an awkward crosscurrent. The tape is stress-off (VIX in the 97th percentile, S&P off highs, 10y at 4.61%, market PE 26.2), which punishes pre-profit SaaS story-stocks even with a modest 0.83 beta, because the archetype - not the beta - is what gets sold. On top of that, Q2 was a classic 'beat but sell': revenue +18%, SaaS ARR +52%, guide raised, yet shares dropped ~7% as the market focused on deal delays, margin pressure, and the fact that implied growth needed to justify valuation is ~39%. That is the definition of a narrative running slightly ahead of what the print delivered. The turnaround/AI-data-security narrative (moderate intensity, moderate durability, low cult) is intact but not strong enough to override a hostile tape and a fresh disappointment reaction. There is no euphoric bid to lean on, and no dedicated fanbase to defend the name into weakness. Analyst tone from the coverage is constructive on SaaS transition but flagged margin and deal-timing concerns - a mixed, not supportive, backdrop. Net: the pressure vector points down over the next several weeks.
Verify before trusting this (4)
- Whether the post-print selling extends past 1-2 weeks or stabilizes as SaaS-transition bulls step in
- Analyst target revisions in the days after the print - direction and dispersion
- Any softening in the VIX/rates backdrop that would let unprofitable SaaS re-rate
- Peer prints (CRWD, ZS, S) that could either validate or undercut the AI-security narrative
This lens hasn't been run for this ticker yet.
When we made this prediction on Aug 1, 2026, VRNS was $39.95. We expect it to be $37.00 by Feb 2027, and we consider it great value under $32.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 1, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.